Prime Medicine, Inc. (PRME)

$5.31

-0.27

(-4.76%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $5.25
    $5.52
    $5.31
    downward going graph

    1.13%

    Downside

    Day's Volatility :4.89%

    Upside

    3.8%

    downward going graph
  • $4.11
    $15.75
    $5.31
    downward going graph

    22.6%

    Downside

    52 Weeks Volatility :73.9%

    Upside

    66.29%

    downward going graph

Returns

PeriodPrime Medicine, Inc.Index (Russel 2000)
3 Months
10.98%
0.0%
6 Months
-20.82%
0.0%
1 Year
-64.66%
0.0%
3 Years
-65.48%
-20.8%

Highlights

Market Capitalization
657.8M
Book Value
$2.11
Earnings Per Share (EPS)
-2.18
Wall Street Target Price
14.1
Profit Margin
0.0%
Operating Margin TTM
-8179.53%
Return On Assets TTM
-39.71%
Return On Equity TTM
-78.27%
Revenue TTM
591.0K
Revenue Per Share TTM
0.01
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-86.7M
EBITDA
-194.7M
Diluted Eps TTM
-2.18
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.68
EPS Estimate Next Year
-1.54
EPS Estimate Current Quarter
-0.47
EPS Estimate Next Quarter
-0.45

Analyst Recommendation

Buy
    76%Buy
    23%Hold
    0
    0%Sell
Based on 17 Wall street analysts offering stock ratings for Prime Medicine, Inc.(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
10
10
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 165.54%

Current $5.31
Target $14.10

Technicals Summary

Sell

Neutral

Buy

Prime Medicine, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Prime Medicine, Inc.
Prime Medicine, Inc.
-11.44%
-20.82%
-64.66%
-65.48%
-65.48%
Moderna, Inc.
Moderna, Inc.
-9.19%
21.5%
-4.18%
-62.27%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.99%
12.81%
44.78%
82.21%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.34%
24.69%
58.81%
196.23%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.88%
11.69%
35.62%
150.46%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Prime Medicine, Inc.
Prime Medicine, Inc.
NA
NA
NA
-1.68
-0.78
-0.4
NA
2.11
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Prime Medicine, Inc.
Prime Medicine, Inc.
Buy
$657.8M
-65.48%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Prime Medicine, Inc.

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 123.5%

Institutional Holdings

  • Alphabet Inc

    12.55%
  • ARK Investment Management LLC

    4.99%
  • Vanguard Group Inc

    4.83%
  • FMR Inc

    3.27%
  • BlackRock Inc

    3.13%
  • Sumitomo Mitsui Trust Holdings Inc

    2.80%

Company Information

Organization
Prime Medicine, Inc.
Employees
234
CEO
Dr. Keith Michael Gottesdiener Ph.D.
Industry
Miscellaneous

FAQs